Clinical Trial Update: Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease

View source ↗

Summary

A completed clinical trial investigating biomarkers in pulmonary hypertension associated with interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Snippet

Sponsor: University of Aarhus | Conditions: Interstitial Lung Disease, Pulmonary Hypertension | Status: COMPLETED